Enliven Therapeutics

ELVN · NASDAQ

$41.25+$2.55 (+6.59%)TodayMarket closed ·
Prev close $38.70

Who owns ELVN

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 61.8% of ELVN’s shares.

  • Fidelity Management & Research Company LLC12.8%
  • OrbiMed Advisors, LLC9.7%
  • Polar Capital LLP9.2%
  • Vestal Point Capital, LP5.7%
  • Next 6 largest institutions24.4%
  • All other shareholders38.2%
Top institutional holders of ELVN
HolderShares% of shares
Fidelity Management & Research Company LLC8.92M12.78%
OrbiMed Advisors, LLC6.78M9.71%
Polar Capital LLP6.43M9.21%
Vestal Point Capital, LP4.00M5.73%
BlackRock Institutional Trust Company, N.A.3.74M5.35%
Commodore Capital LP3.27M4.69%
T. Rowe Price Associates, Inc.2.83M4.06%
Vanguard Capital Management, LLC2.57M3.68%
Dalton Barbara J2.54M3.63%
Citadel Advisors LLC2.07M2.96%

Largest mutual fund holders

Top mutual fund holders of ELVN
HolderShares% of shares
Polar Capital Funds Plc - Healthcare Opportunities Fund3.61M5.17%
Polar Capital Biotechnology Fund2.56M3.66%
Vanguard Total Stock Market Index Fund1.89M2.71%
Statens Pensjonsfond Utland1.38M1.98%
Fidelity Select Health Care Portfolio1.34M1.92%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $65.16M (42 trades) of ELVN on the open market, with no buys.

Latest ELVN insider transactions
InsiderTypeSharesValue
BALL KRISTINE MAward23.39K—
Garland J. ScottOption exercise13.00K—
Garland J. ScottSale13.00K$606.72K
Garland J. ScottOption exercise13.00K$201.11K
Hohl BenjaminOption exercise3.98K—
Hohl BenjaminSale289$14.88K
Hohl BenjaminSale2.19K$111.27K
Hohl BenjaminSale3.54K$176.85K
Hohl BenjaminOption exercise3.98K$59.13K
Collins Helen LouiseOption exercise5.00K—

Short interest

Settled Sep 30, 2026

Shares short
10.36M
Days to cover
5.49
% of shares outstanding
14.83%
Average daily volume
1.89M
Change since last report
+20.1%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.